Christina Grube
Zurich, ZH, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Safety of Bacillus Calmette-Guérin Vaccination and Impact on HIV-1 Latent Reservoir Size in People With Treated HIV-1 Infection.
Journal: Open forum infectious diseases
Published: April 21, 2025
Cohort Profile: The Zurich Primary HIV Infection Study.
Journal: Microorganisms
Published: December 15, 2023
Absence of Proviral Human Immunodeficiency Virus (HIV) Type 1 Evolution in Early-Treated Individuals With HIV Switching to Dolutegravir Monotherapy During 48 Weeks.
Journal: The Journal of infectious diseases
Published: May 05, 2023
Sustained Viral Suppression With Dolutegravir Monotherapy Over 192 Weeks in Patients Starting Combination Antiretroviral Therapy During Primary Human Immunodeficiency Virus Infection (EARLY-SIMPLIFIED): A Randomized, Controlled, Multi-site, Noninferiority Trial.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: February 10, 2023
High Rates of Asymptomatic Mycoplasma genitalium Infections With High Proportion of Genotypic Resistance to First-Line Macrolide Treatment Among Men Who Have Sex With Men Enrolled in the Zurich Primary HIV Infection Study.
Journal: Open forum infectious diseases
Published: April 05, 2022
Detecting Selection in the HIV-1 Genome during Sexual Transmission Events.
Journal: Viruses
Published: December 09, 2021
A Treatment-as-Prevention Trial to Eliminate Hepatitis C Among Men Who Have Sex With Men Living With Human Immunodeficiency Virus (HIV) in the Swiss HIV Cohort Study.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: March 12, 2020
Noninferiority of Simplified Dolutegravir Monotherapy Compared to Continued Combination Antiretroviral Therapy That Was Initiated During Primary Human Immunodeficiency Virus Infection: A Randomized, Controlled, Multisite, Open-label, Noninferiority Trial.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: October 01, 2018
High Number of Potential Transmitters Revealed in a Population-based Systematic Hepatitis C Virus RNA Screening Among Human Immunodeficiency Virus-infected Men Who Have Sex With Men.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: November 14, 2017
High Rates of Subsequent Asymptomatic Sexually Transmitted Infections and Risky Sexual Behavior in Patients Initially Presenting With Primary Human Immunodeficiency Virus-1 Infection.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: July 03, 2017
Interferon α-Enhanced Clearance of Group A Streptococcus Despite Neutropenia.
Journal: The Journal of infectious diseases
Published: January 12, 2016
The impact of vaccination on the breadth and magnitude of the antibody response to influenza A viruses in HIV-infected individuals.
Journal: AIDS (London, England)
Published: September 16, 2015
Last Updated: 09/26/2026